Paper40314847
Mixed lineage kinase (MLK) controls tumor development and angiogenesis.
Kant S and 7 others. Angiogenesis, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Mixed lineage kinase (MLK) controls tumor development and angiogenesis. Papers, record 40314847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40314847
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neovascularization, Pathologic | Major topic |
| MAP Kinase Kinase Kinases | Major topic |
| Lung Neoplasms | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Mitogen-Activated Protein Kinase Kinase Kinase 11 | |
| Gene Expression Regulation, Neoplastic | |
| RNA, Long Noncoding | |
| Cell Proliferation | |
| Angiogenesis |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 25POST1373333 | American Heart Association | PubMed | PubMed | ||
| R03 CA295675 | NCI NIH HHS | United States | R03CA295675 | PubMed and NIH | NIH RePORTER |
| R03 TR004452 | NCATS NIH HHS | United States | R03TR004452 | PubMed and NIH | NIH RePORTER |
| R01 HL151626 | NHLBI NIH HHS | United States | R01HL151626 | PubMed and NIH | NIH RePORTER |
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21832056 | Alteration of developmental and pathological retinal angiogenesis in angptl4-deficient mice. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21832056 | PubMed |
| 2 | 23209177 | The role of the tumor microenvironment in regulating angiogenesis. | Cold Spring Harb Perspect Med | 2012 | https://conductscience.org/library/papers/23209177 | PubMed |
| 3 | 12209126 | Mixed-lineage kinase control of JNK and p38 MAPK pathways. | Nat Rev Mol Cell Biol | 2002 | https://conductscience.org/library/papers/12209126 | PubMed |
| 4 | 21593862 | Molecular mechanisms and clinical applications of angiogenesis. | Nature | 2011 | https://conductscience.org/library/papers/21593862 | PubMed |
| 5 | 30258904 | The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism. | Genes Dis | 2017 | https://conductscience.org/library/papers/30258904 | PubMed |
| 6 | 7917273 | Expression of the imprinted gene H19 in the human fetus. | Mol Reprod Dev | 1994 | https://conductscience.org/library/papers/7917273 | PubMed |
| 7 | 11057897 | Signal transduction by the JNK group of MAP kinases. | Cell | 2000 | https://conductscience.org/library/papers/11057897 | PubMed |
| 8 | 24259426 | MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. | Hepatology | 2014 | https://conductscience.org/library/papers/24259426 | PubMed |
| 9 | 28930674 | A Protein Scaffold Coordinates SRC-Mediated JNK Activation in Response to Metabolic Stress. | Cell Rep | 2017 | https://conductscience.org/library/papers/28930674 | PubMed |
| 10 | 24634660 | Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. | Front Physiol | 2014 | https://conductscience.org/library/papers/24634660 | PubMed |
| 11 | 31270248 | JNK and cardiometabolic dysfunction. | Biosci Rep | 2019 | https://conductscience.org/library/papers/31270248 | PubMed |
| 12 | 18850197 | The role of microenvironment in tumor angiogenesis. | Genes Nutr | 2008 | https://conductscience.org/library/papers/18850197 | PubMed |
| 13 | 39213161 | Endothelial Reactive Oxygen Species: Key Players in Cardiovascular Health and Disease. | Antioxid Redox Signal | 2025 | https://conductscience.org/library/papers/39213161 | PubMed |
| 14 | 8636440 | H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8636440 | PubMed |
| 15 | 22975805 | The transcriptional landscape and mutational profile of lung adenocarcinoma. | Genome Res | 2012 | https://conductscience.org/library/papers/22975805 | PubMed |
| 16 | 36038020 | The role of mixed lineage kinase 3 (MLK3) in cancers. | Pharmacol Ther | 2022 | https://conductscience.org/library/papers/36038020 | PubMed |
| 17 | 26039997 | Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26039997 | PubMed |
| 18 | 38166752 | The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38166752 | PubMed |
| 19 | 23954791 | Role of the mixed-lineage protein kinase pathway in the metabolic stress response to obesity. | Cell Rep | 2013 | https://conductscience.org/library/papers/23954791 | PubMed |
| 20 | 11025665 | Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. | Nat Cell Biol | 2000 | https://conductscience.org/library/papers/11025665 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42178457 | Neointimal hyperplasia and vascular restenosis: from molecular mechanisms to therapeutic interventions. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42178457 | PubMed |
| 40759816 | Development and validation of a hypoxia-immune-based microenvironment gene signature for predicting survival in non-small cell lung cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40759816 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADAM8 | 101 | PubTator's text mining | https://conductscience.org/library/genes/101 | NCBI Gene |
| ANGPTL4 | 51129 | PubTator's text mining | https://conductscience.org/library/genes/51129 | NCBI Gene |
| H19 | 283120 | PubTator's text mining | https://conductscience.org/library/genes/283120 | NCBI Gene |
| MAP3K10 | 4294 | PubTator's text mining | https://conductscience.org/library/genes/4294 | NCBI Gene |
| MAP3K11 | 4296 | PubTator's text mining | https://conductscience.org/library/genes/4296 | NCBI Gene |
| MAP3K13 | 9175 | PubTator's text mining | https://conductscience.org/library/genes/9175 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| PGF | 5228 | PubTator's text mining | https://conductscience.org/library/genes/5228 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE40419 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40314847
GET https://conductscience.org/api/papers/v1/40314847/references?page=2